Company Filing History:
Years Active: 2014-2016
Title: Terrence Kantner: Innovator in Glycosylation Techniques
Introduction
Terrence Kantner is a notable inventor based in Bath, GB. He has made significant contributions to the field of glycosylation, with a focus on developing materials and methods that enhance biological properties of therapeutic moieties. His innovative work has led to the filing of three patents, showcasing his expertise and dedication to advancing scientific knowledge.
Latest Patents
Kantner's latest patents include groundbreaking techniques related to glycosylation. One patent describes methods for producing glycosylation structures that are resistant to enzymatic degradation. This innovation allows for the modulation of biological properties of therapeutic moieties. Another patent focuses on functionalizing polypeptides with moieties and glycan groups. This involves using a functionalizing reagent that reacts with thiol groups in polypeptides, thereby linking them to poly(alkylene glycol) molecules or glycan groups.
Career Highlights
Terrence Kantner is currently associated with Glythera Limited, where he continues to push the boundaries of glycosylation research. His work has been instrumental in developing new methodologies that have potential applications in therapeutic settings. His contributions to the field are recognized and valued by his peers.
Collaborations
Kantner collaborates with esteemed colleagues, including Andrew Graham Watts and Amanda Barbara MacKenzie. These partnerships enhance the research environment and foster innovation within the team.
Conclusion
Terrence Kantner's work in glycosylation techniques exemplifies his commitment to innovation in the field. His patents and collaborations reflect a dedication to advancing therapeutic applications, making him a significant figure in contemporary scientific research.